Cellularized Biomaterials Used as Gingival Connective Tissue Substitutes In Vivo: A Systematic Review.

IF 5.1 2区 医学 Q2 CELL & TISSUE ENGINEERING
Camille Déchelette, Rawen Smirani, Chantal Médina, Adrien Naveau
{"title":"Cellularized Biomaterials Used as Gingival Connective Tissue Substitutes <i>In Vivo</i>: A Systematic Review.","authors":"Camille Déchelette, Rawen Smirani, Chantal Médina, Adrien Naveau","doi":"10.1089/ten.TEB.2024.0031","DOIUrl":null,"url":null,"abstract":"<p><p>Developing an <i>in vitro</i> model of gingival connective tissue that mimics the original structure and composition of gingiva for clinical grafting is relevant for personalized treatment of missing gingiva. Using tissue engineering techniques allows bypassing limitations encountered with existing solutions to increase oral soft tissue volume. This review aims to systematically analyze the different currently existing cellularized materials and technologies used to engineer gingival substitutes for <i>in vivo</i> applications. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. An electronic search on PubMed, Scopus, Web of Science, and Cochrane Library databases was conducted to identify suitable studies. <i>In vivo</i> studies about gingival substitutes and grafts containing oral cells compared with a control to investigate the graft remodeling were included. Risk of bias in the included studies was assessed using the Systematic Review Center for Laboratory animal Experimentation (SYRCLE) 10-item checklist. Out of 631 screened studies, 19 were included. Animal models were mostly rodents, and the most used implantation was subcutaneous. According to the SYRCLE tool, low-to-unclear risk of bias was prevalent. Studies checked vascularization and extracellular remodeling up to 60 days after implantation of the cellularized biomaterial. Cells used were mostly fibroblasts and stem cells from oral origin. Grafts presenting vascularization potential after implantation were produced by tissue engineering technologies including cell seeding or embedding for 14, cell sheets for 2, microsphere for 1, and extrusion 3D bioprinting for 2. Components used to build the scaffold containing the cells are all naturally derived and are mainly fibrin, gelatin, collagen, agarose, alginate, fibroin, guar gum, hyaluronic acid, and decellularized extracellular matrix. The most recurring crosslinking method was using chemicals. All studies except one reported vascularization of the graft after implantation, and some detailed extracellular matrix remodeling. Current solutions are not efficient enough. By assessing the relevant studies on the subject, this systematic review showed that a diversity of cellularized biomaterials substituting gingival connective tissue enables vascularization and extracellular remodeling. Taking the results of this review into account could help improve current bio-inks used in 3D bioprinting for <i>in vivo</i> applications compensating for gingival loss.</p>","PeriodicalId":23134,"journal":{"name":"Tissue Engineering. Part B, Reviews","volume":null,"pages":null},"PeriodicalIF":5.1000,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue Engineering. Part B, Reviews","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/ten.TEB.2024.0031","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

Developing an in vitro model of gingival connective tissue that mimics the original structure and composition of gingiva for clinical grafting is relevant for personalized treatment of missing gingiva. Using tissue engineering techniques allows bypassing limitations encountered with existing solutions to increase oral soft tissue volume. This review aims to systematically analyze the different currently existing cellularized materials and technologies used to engineer gingival substitutes for in vivo applications. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. An electronic search on PubMed, Scopus, Web of Science, and Cochrane Library databases was conducted to identify suitable studies. In vivo studies about gingival substitutes and grafts containing oral cells compared with a control to investigate the graft remodeling were included. Risk of bias in the included studies was assessed using the Systematic Review Center for Laboratory animal Experimentation (SYRCLE) 10-item checklist. Out of 631 screened studies, 19 were included. Animal models were mostly rodents, and the most used implantation was subcutaneous. According to the SYRCLE tool, low-to-unclear risk of bias was prevalent. Studies checked vascularization and extracellular remodeling up to 60 days after implantation of the cellularized biomaterial. Cells used were mostly fibroblasts and stem cells from oral origin. Grafts presenting vascularization potential after implantation were produced by tissue engineering technologies including cell seeding or embedding for 14, cell sheets for 2, microsphere for 1, and extrusion 3D bioprinting for 2. Components used to build the scaffold containing the cells are all naturally derived and are mainly fibrin, gelatin, collagen, agarose, alginate, fibroin, guar gum, hyaluronic acid, and decellularized extracellular matrix. The most recurring crosslinking method was using chemicals. All studies except one reported vascularization of the graft after implantation, and some detailed extracellular matrix remodeling. Current solutions are not efficient enough. By assessing the relevant studies on the subject, this systematic review showed that a diversity of cellularized biomaterials substituting gingival connective tissue enables vascularization and extracellular remodeling. Taking the results of this review into account could help improve current bio-inks used in 3D bioprinting for in vivo applications compensating for gingival loss.

用作体内牙龈结缔组织替代物的细胞化生物材料:系统性综述》(Cellularised Biomaterials Used as Gingival Connective Tissue Substitutes In Vivo: Systematic Review.
开发牙龈结缔组织的体外模型,模仿牙龈的原始结构和组成进行临床移植,对于牙龈缺失的个性化治疗具有重要意义。利用组织工程技术可以绕过现有解决方案的局限性,增加口腔软组织的体积。本综述旨在系统分析目前用于体内应用牙龈替代物工程的不同细胞化材料和技术。本综述遵循系统综述和元分析首选报告项目(PRISMA)指南。在 PubMed、Scopus、Web of Science 和 Cochrane Library 数据库中进行了电子检索,以确定合适的研究。其中包括有关牙龈替代物和含有口腔细胞的移植物与对照组进行比较以研究移植物重塑的体内研究。采用实验动物实验系统综述中心(SYRCLE)的 10 项检查表对纳入研究的偏倚风险进行了评估。在筛选出的 631 项研究中,有 19 项被纳入。动物模型主要是啮齿类动物,最常用的植入方式是皮下注射。根据 SYRCLE 工具,普遍存在低至不明确的偏倚风险。研究检查了细胞化生物材料植入后 60 天内的血管形成和细胞外重塑情况。使用的细胞主要是成纤维细胞和口腔干细胞。植入后具有血管化潜能的移植物是通过组织工程技术制成的,其中细胞播种或包埋14例,细胞片2例,微球1例,挤压三维生物打印2例。用于构建含有细胞的支架的成分都是天然提取的,主要有纤维蛋白、明胶、胶原蛋白、琼脂糖、藻酸盐、纤维素、瓜尔胶、透明质酸和脱细胞细胞外基质。最常见的交联方法是使用化学品。除一项研究外,其他所有研究都报告了移植物在植入后的血管化情况以及细胞外基质重塑的详细情况。目前的解决方案不够有效。通过对相关研究的评估,本系统性综述显示,替代牙龈结缔组织的多种细胞化生物材料可实现血管化和细胞外基质重塑。将本综述的结果作为参考,有助于改善目前用于三维生物打印的生物墨水,以弥补牙龈缺损的体内应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Tissue Engineering. Part B, Reviews
Tissue Engineering. Part B, Reviews Biochemistry, Genetics and Molecular Biology-Biochemistry
CiteScore
12.80
自引率
1.60%
发文量
150
期刊介绍: Tissue Engineering Reviews (Part B) meets the urgent need for high-quality review articles by presenting critical literature overviews and systematic summaries of research within the field to assess the current standing and future directions within relevant areas and technologies. Part B publishes bi-monthly.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信